A new report shows barely a quarter of board members cite CEO succession as a top priority.

Medtronic announced a spin-off of its diabetes business in May, which will be completed in 2026. Read more on MDT stock here.

Although the company's advancements have influenced contemporary healthcare, its stock presents a more cautious narrative ...

While Medtronic has struggled to keep up with the broader market over the past year, analysts remain fairly upbeat on its ...

Tandem (TNDM) stock falls and Insulet (PODD) stock gains as investors react to the companies' Q2 2025 results and guidance.

In a pooled analysis of three randomized trials, CPAP had overall null cardiovascular effects in patients with obstructive ...

The president who ran on his business acumen isn’t holding back in telling corporate bosses how to run their companies—or ...

Medtronic's separation of its Medtronic Diabetes unit into a publicly traded company named MiniMed will be a new beginning ...

Medtronic also disclosed severance for a former SVP, and pay for its median employee, and a slight decrease in global ...

Orchestra BioMed reported that it has secured over $111 million in financing through a series of transactions and ...

Overview of the MarketThe global Medical Robots Market is valued at USD 31.11 billion in 2024 and is projected to reach a ...

Medtronic (MDT) concluded the recent trading session at $91.24, signifying a +2.1% move from its prior day's close.